Physician

Vivian Y Kim, M.D.

According to 2025 Medicare claims, Vivian Kim, M.D. (NPI: 1669560041) practices ophthalmology in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is ADVANCED RETINA CARE (NPI: 1326437708; TIN: 472414520) and primary practice location at 93720-0359.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 21,994 HCPCS/CPT codes, and received $1,356,969 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 326 prescription claims across 61 beneficiaries totaling $36,165 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 18 records totaling $868. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $824,220 to $1,356,969. Similarly, Part D prescription costs have fallen sharply in recent years, from $28,241 to $36,165. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $824,220 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,269,888 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,810,229 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,725,961 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,838,184 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,641,533 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,534,287 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,422,755 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,387,520 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,356,969 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153264,285$824,220
201662211,164$2,269,888
201787413,716$2,810,229
20181,15117,277$3,725,961
20191,20018,098$3,838,184
20201,13917,111$3,641,533
20211,14615,927$3,534,287
202290514,286$2,422,755
202324217,296$1,387,520
202419921,994$1,356,969

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$67K$134K2015 Drug cost: $28,241 (USD; Tot_Drug_Cst)2016 Drug cost: $48,833 (USD; Tot_Drug_Cst)2017 Drug cost: $61,108 (USD; Tot_Drug_Cst)2018 Drug cost: $87,817 (USD; Tot_Drug_Cst)2019 Drug cost: $102,582 (USD; Tot_Drug_Cst)2020 Drug cost: $134,103 (USD; Tot_Drug_Cst)2021 Drug cost: $104,994 (USD; Tot_Drug_Cst)2022 Drug cost: $93,229 (USD; Tot_Drug_Cst)2023 Drug cost: $40,074 (USD; Tot_Drug_Cst)2024 Drug cost: $36,165 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201576215$28,241
2016116401$48,833
2017159535$61,108
2018181676$87,817
2019192713$102,582
2020193827$134,103
2021157644$104,994
2022117492$93,229
202365271$40,074
202461326$36,165

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg49478$659
67028Injection of drug into eye99820$95
92014Established patient complete exam of visual system156267$90
92012Established patient problem focused exam of visual system138587$75
92134Imaging of retina189838$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DifluprednateDifluprednate532,154$6,324
Bromfenac SodiumBromfenac Sodium24760$3,022
Loteprednol EtabonateLoteprednol Etabonate22637$2,147
Brimonidine TartrateBrimonidine Tartrate271,260$1,636
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat322,855$908

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$868Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vivian Y. Kim, M.D.?

Tedicare shows public-source Medicare data for Vivian Y. Kim, M.D. (NPI 1669560041), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vivian Y. Kim, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vivian Y. Kim, M.D.?

Vivian Y. Kim, M.D. is linked to ADVANCED RETINA CARE (billing NPI 1326437708) in the available physician profile data.

Does Vivian Y. Kim, M.D. have Open Payments data?

Vivian Y. Kim, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.